Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 34,354 followers.

Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines https://t.co/bPvDL35yNn

Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines https://t.co/92nDjBZuO1

Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines https://t.co/qxaQZcHGZQ

New article: Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines https://t.co/71ZQDSFHTW #melanoma #oncology https://t.co/GLjsUES6dd

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.